Pancreatic neuroendocrine tumors: contemporary diagnosis and management

Hosp Pract (1995). 2016 Aug;44(3):109-19. doi: 10.1080/21548331.2016.1210474. Epub 2016 Jul 18.

Abstract

Pancreatic neuroendocrine tumors (PNETs) are neoplasms that arise from the hormone producing cells of the islets of Langerhans, also known as pancreatic islet cells. PNETs are considered a subgroup of neuroendocrine tumors, and have unique biology, natural history and clinical management. These tumors are classified as 'functional' or 'non-functional' depending on whether they release peptide hormones that produce specific hormone- related symptoms, usually in established patterns based on tumor subtype. This manuscript will review pancreatic neuroendocrine tumor subtypes, syndromes, diagnosis, and clinical management.

Keywords: Pancreatic neuroendocrine tumors; VIPoma; gastrinoma; glucagonoma; insulinoma; somatostatinoma.

Publication types

  • Review

MeSH terms

  • Carcinoma, Islet Cell / physiopathology
  • Carcinoma, Islet Cell / therapy
  • Humans
  • Insulinoma / physiopathology
  • Insulinoma / therapy
  • Islets of Langerhans
  • Multiple Endocrine Neoplasia Type 1 / physiopathology
  • Multiple Endocrine Neoplasia Type 1 / therapy
  • Neoplasm Grading
  • Neoplasm Staging
  • Neuroendocrine Tumors / diagnosis*
  • Neuroendocrine Tumors / physiopathology
  • Neuroendocrine Tumors / therapy*
  • Pancreatic Hormones
  • Pancreatic Neoplasms / diagnosis*
  • Pancreatic Neoplasms / physiopathology
  • Pancreatic Neoplasms / therapy*
  • Peptide Hormones
  • Racial Groups
  • Sex Factors

Substances

  • Pancreatic Hormones
  • Peptide Hormones